• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    90 Biggest Movers From Yesterday

    5/13/22 5:44:49 AM ET
    $ABVC
    $ACXP
    $AFI
    $AFRM
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABVC alert in real time by email

    Gainers

    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
    • Squarespace, Inc. (NYSE:SQSP) jumped 48.5% to close at $21.44 after the company reported better-than-expected Q1 sales results and issued Q2 and FY22 sales guidance above analyst estimates. The company also announced a buyback program of up to $200 million.
    • Lordstown Motors Corp. (NASDAQ:RIDE) jumped 47% to close at $2.22. Lordstown Motors completed a deal to sell certain assets to Foxconn.
    • Jupai Holdings Limited (NYSE:JP) gained 44% to settle at $0.75.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) jumped 38.8% to close at $0.2220. Salarius Pharmaceuticals successfully completed the pre-IND meeting process with the FDA for SP-3164 in hematological cancers and solid tumors.
    • MoneyLion Inc. (NYSE:ML) gained 35.5% to settle at $1.64 after the company reported better-than-expected Q1 EPS and sales results. The company reaffirmed FY22 guidance.
    • Diebold Nixdorf, Incorporated (NYSE:DBD) gained 35.1% to settle at $3.08. Diebold Nixdorf recently reported worse-than-expected Q1 results and cut FY22 guidance.
    • AppLovin Corporation (NASDAQ:APP) shares climbed 34.7% to close at $36.74 after the company reported better-than-expected Q1 sales results and announced a $750 million share buyback.
    • Kubient, Inc. (NASDAQ:KBNT) gained 34.5% to settle at $0.9976.
    • SunOpta Inc. (NASDAQ:STKL) climbed 31.7% to close at $6.44 following upbeat quarterly earnings.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) gained 31.5% to close at $0.25 after the company announced the FDA has granted Orphan Drug Designation for elamipretide for the treatment duchenne muscular dystrophy.
    • Bakkt Holdings, Inc. (NASDAQ:BKKT) shares jumped 30.2% to close at $2.80 after dipping 19% on Wednesday.
    • SQL Technologies Corp. (NASDAQ:SKYX) rose 30% to close at $4.85.
    • Bumble Inc. (NASDAQ:BMBL) gained 26.8% to close at $22.36 after the company reported better-than-expected Q1 EPS and sales results.
    • Purple Innovation, Inc. (NASDAQ:PRPL) rose 25.4% to settle at $4.10. Purple Innovation reported better-than-expected Q1 EPS and sales results.
    • Compass Therapeutics, Inc. (NASDAQ:CMPX) gained 25% to close at $2.30. Compass Therapeutics recently posted a Q1 loss of $0.07 per share.
    • Carvana Co. (NYSE:CVNA) climbed 24.7% to close at $37.40. Stifel recently downgraded Carvana from Buy to Hold and lowered the price target from $115 to $40.
    • Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) gained 24.6% to close at $3.45. Concert Pharmaceuticals recently posted a Q1 loss of $1.03 per share.
    • 89bio, Inc. (NASDAQ:ETNB) surged 24.2% to close at $2.67 following Q1 earnings.
    • SciSparc Ltd. (NASDAQ:SPRC) rose 23.4% to settle at $2.90.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) gained 23.3% to settle at $18.04. Affirm reported better-than-expected Q3 EPS and sales results after the closing bell.
    • Cullinan Oncology, Inc. (NASDAQ:CGEM) rose 23.1% to close at $9.00 after the company and Taiho Pharmaceutical announced a strategic collaboration to jointly develop and commercialize CLN-081/TAS6417 and Taiho's acquisition of Cullinan Pearl.
    • Caribou Biosciences, Inc. (NASDAQ:CRBU) gained 22.2% to close at $8.10. Caribou Biosciences announced initial data for CB-010 anti-CD19 allogeneic CAR-T cell therapy to be presented at EHA 2022 Hybrid Congress Jun. 9-17.
    • Ontrak, Inc. (NASDAQ:OTRK) jumped 21.8% to settle at $1.34 following Q1 results.
    • Rail Vision Ltd. (NASDAQ:RVSN) rose 21.8% to close at $1.34. Knorr-Bremse Systeme für Schienenfahrzeuge reported in 13D Filing a new stake of 36.8% in Rail Vision.
    • ViewRay, Inc. (NASDAQ:VRAY) gained 21.6% to close at $2.98.
    • Redfin Corporation (NASDAQ:RDFN) rose 21.3% to settle at $10.69.
    • Sharecare, Inc. (NASDAQ:SHCR) surged 20.4% to close at $2.36 after the company reported better-than-expected Q1 EPS and sales results, issued Q2 and FY22 guidance and reported a $50 million buyback.
    • Traeger, Inc. (NYSE:COOK) gained 20% to close at $5.29 after the company reported better-than-expected Q1 EPS and sales results and issued guidance.
    • AlloVir, Inc. (NASDAQ:ALVR) jumped 19.9% to close at $3.91.
    • EVgo, Inc. (NASDAQ:EVGO) rose 19.7% to settle at $8.58 after Credit Suisse upgraded the stock from Neutral to Outperform and announced a $14 price target.
    • Berkeley Lights, Inc. (NASDAQ:BLI) jumped 19.5% to close at $4.50. Berkeley Lights recently posted a Q1 loss of $0.32 per share.
    • Roblox Corporation (NYSE:RBLX) gained 19.2% to close at $28.58. Roblox recently reported worse-than-expected Q1 EPS and sales results.
    • Ondas Holdings Inc. (NASDAQ:ONDS) jumped 19.1% to settle at $6.04. Ondas Holdings recently posted Q1 loss of $0.24 per share.
    • Vapotherm, Inc. (NYSE:VAPO) gained 19% to close at $3.44.
    • Marqeta, Inc. (NASDAQ:MQ) rose 18.9% to settle at $7.88 after the company reported better-than-expected Q1 sales results and issued Q2 sales growth guidance.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) rose 18.8% to close at $0.25.
    • Coupang, Inc. (NYSE:CPNG) shares climbed 18.5% to settle at $11.46 after the company reported better-than-expected Q1 EPS results.
    • Rivian Automotive, Inc. (NASDAQ:RIVN) gained 18% to close at $24.30 after the company reported better-than-expected Q1 EPS results.
    • Rekor Systems, Inc. (NASDAQ:REKR) gained 17.2% to close at $2.59.
    • Unity Software Inc. (NYSE:U) gained 15.8% to close at $35.09. Unity Software recently reported worse-than-expected Q1 sales results and issued Q2 and FY22 sales guidance below analyst estimates.
    • Olo Inc. (NYSE:OLO) climbed 15.7% to settle at $11.21. Olo posted Q1 adjusted EPS of $0.01.
    • Sierra Wireless, Inc. (NASDAQ:SWIR) surged 15.2% to close at $18.79 following strong Q1 earnings.
    • DarioHealth Corp. (NASDAQ:DRIO) rose 13.4% to close at $5.18 following strong Q1 results.
    • Omeros Corporation (NASDAQ:OMER) climbed 13% to close at $2.95. The company recent posted upbeat quarterly earnings.
    • Groupon, Inc. (NASDAQ:GRPN) jumped 11.8% to close at $14.23. Groupon 10% owner Pale Fire Capital SE acquired a total of 1,651,277 shares at an average price of $14.31.
    • GameStop Corp. (NYSE:GME) rose 10.1% to close at $89.57.
    • Enovix Corporation (NASDAQ:ENVX) rose 9.6% to close at $8.23 after the company posted Q1 earnings.
    • ClearPoint Neuro, Inc. (NASDAQ:CLPT) gained 9.2% to close at $7.74 after the company reported better-than-expected Q1 EPS and sales results and issued FY22 revenue guidance above analyst estimates.
    • STMicroelectronics N.V. (NYSE:STM) rose 5.6% to close at $37.02. STMicroelectronics said it sees over $20 billion in annual sales by 2027.


    Losers

    • Tenon Medical, Inc. (NASDAQ:TNON) shares tumbled 75.7% to settle at $8.86 on Thursday.
    • Atento S.A. (NYSE:ATTO) shares fell 36.1% to close at $14.93 on Thursday after reporting Q1 results.
    • AppTech Payments Corp. (NASDAQ:APCX) declined 34.8% to close at $0.8086. AppTech Payments recently reported Q1 sales of $104,000.
    • Rockwell Medical, Inc. (NASDAQ:RMTI) dropped 32.5% to close at $0.2158 after the company announced a 1-for-11 reverse stock split, effective May 13, 2022.
    • Eve Holding Inc. (NYSE:EVEX) fell 31.3% to close at $6.44.
    • MOGU Inc. (NYSE:MOGU) dropped 28.3% to close at $1.44.
    • Chicken Soup for the Soul Entertainment, Inc. (NASDAQ:CSSE) fell 27% to close at $5.21. Chicken Soup For The Soul Entertainment agreed to acquire entertainment company Redbox Entertainment.
    • Dutch Bros Inc. (NYSE:BROS) shares fell 26.9% to close at $25.11 after the company reported worse-than-expected Q1 EPS results and issued FY22 revenue guidance below analyst estimates.
    • Marpai, Inc. (NASDAQ:MRAI) fell 26.7% to close at $0.9239 after the company reported Q1 earnings results.
    • Applied Blockchain, Inc. (NASDAQ:APLD) fell 26.5% to close at $1.80.
    • Intellicheck, Inc. (NASDAQ:IDN) fell 26.3% to settle at $1.43 after the company postponed its Q1 earnings report.
    • Eargo, Inc. (NASDAQ:EAR) declined 24.7% to close at $1.28 after the company announced its inability to file the Q1 2022 Form 10-Q on a timely basis and said Nasdaq may take additional actions as a result.
    • Helius Medical Technologies, Inc. (NASDAQ:HSDT) dropped 23.7% to close at $1.48 following weak quarterly earnings.
    • Mogo Inc. (NASDAQ:MOGO) fell 23.5% to settle at $1.04 following Q1 results.
    • Pulse Biosciences, Inc. (NASDAQ:PLSE) dropped 23.3% to close at $1.48 following weak quarterly results.
    • iClick Interactive Asia Group Limited (NASDAQ:ICLK) fell 23.1% to close at $0.6290.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) declined 22.7% to close at $0.46. Cidara Therapeutics posted a Q1 loss of $0.27 per share.
    • Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) fell 22.3% to close at $2.61. Acurx Pharmaceuticals posted Q1 2022 R&D expenses of $800K.
    • Digital Media Solutions, Inc. (NYSE:DMS) fell 21.8% to close at $1.40.
    • Outbrain Inc. (NASDAQ:OB) dipped 20.4% to close at $6.28 after reporting Q1 results.
    • iMedia Brands, Inc. (NASDAQ:IMBI) fell 20.1% to close at $2.35 after the company announced pricing of $24 million registered direct offering.
    • AcuityAds Holdings Inc. (NASDAQ:ATY) fell 19.1% to close at $1.86. AcuityAds Holdings posted a Q1 loss of $0.07 per share.
    • FingerMotion, Inc. (NASDAQ:FNGR) declined 18.9% to settle at $1.24.
    • Armstrong Flooring, Inc. (NYSE:AFI) shares declined 18.4% to close at $0.3998. Armstrong Flooring shares jumped 237% on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
    • Societal CDMO, Inc. (NASDAQ:SCTL) fell 18% to close at $0.9999 following Q1 results.
    • Usio, Inc. (NASDAQ:USIO) fell 17.6% to close at $1.99 following wider-than-expected quarterly loss.
    • Rockley Photonics Holdings Limited (NYSE:RKLY) fell 16.8% to close at $2.33 after the company reported Q1 results and announced a $81.5 million private placement.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) fell 16.3% to settle at $2.68. Chicken Soup For The Soul Entertainment Inc (NASDAQ:CSSE) agreed to acquire entertainment company Redbox Entertainment.
    • Mawson Infrastructure Group, Inc. (NASDAQ:MIGI) dropped 16.2% to close at $2.43 as the company issued April 2022 bitcoin self-mining, hosting co-location and operational update.
    • ABVC BioPharma, Inc. (NASDAQ:ABVC) dipped 13.8% to close at $2.12 after announcing a $4.22 million registered direct offering.
    • Docebo Inc. (NASDAQ:DCBO) declined 13.2% to close at $29.72 after reporting a wider quarterly loss.
    • Verb Technology Company, Inc. (NASDAQ:VERB) fell 11.8% to close at $0.3014 after declining 32% on Wednesday.
    • Fluence Energy, Inc. (NASDAQ:FLNC) fell 11% to close at $6.31.
    • Manulife Financial Corporation (NYSE:MFC) fell 10.5% to close at $16.76 after the company reported Q1 earnings results.
    • The Vita Coco Company, Inc. (NASDAQ:COCO) dropped 9.1% to close at $9.08 following Q1 results.
    • WaveDancer, Inc. (NASDAQ:WAVD) declined 8% to close at $2.8797.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) fell 7.7% to close at $0.2456. Regulus Therapeutics shares jumped around 55% on Wednesday after the company announced the FDA has accepted its Investigational New Drug Application for RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) fell 6.5% to close at $3.60. Pear Therapeutics announced inclusion of QuickMD in its telehealth provider experience initiative.
    • Eneti Inc. (NYSE:NETI) slipped 5.5% to close at $5.63 following Q1 results.
    • Fossil Group, Inc. (NASDAQ:FOSL) declined 5% to close at $7.61 after the company reported worse-than-expected Q1 sales results and adjusted EPS results were lower year over year. The company also cut FY22 net sales guidance.
    Get the next $ABVC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABVC
    $ACXP
    $AFI
    $AFRM

    CompanyDatePrice TargetRatingAnalyst
    Solana Company
    $HSDT
    4/23/2026$3.00Buy
    B. Riley Securities
    STMicroelectronics N.V.
    $STM
    4/23/2026$58.00Hold → Buy
    Craig Hallum
    Roblox Corporation
    $RBLX
    4/22/2026$140.00 → $125.00Buy
    Goldman
    Affirm Holdings Inc.
    $AFRM
    4/22/2026$75.00Outperform
    BMO Capital Markets
    Fluence Energy Inc.
    $FLNC
    4/17/2026$8.00Neutral → Sell
    UBS
    STMicroelectronics N.V.
    $STM
    4/17/2026$48.00Neutral → Outperform
    Mizuho
    Applovin Corporation
    $APP
    4/14/2026$520.00Buy
    Argus
    Applovin Corporation
    $APP
    4/9/2026$710.00Outperform
    Macquarie
    More analyst ratings

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Solana Company with a new price target

    B. Riley Securities initiated coverage of Solana Company with a rating of Buy and set a new price target of $3.00

    4/23/26 8:09:25 AM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    STMicroelectronics upgraded by Craig Hallum with a new price target

    Craig Hallum upgraded STMicroelectronics from Hold to Buy and set a new price target of $58.00

    4/23/26 7:57:36 AM ET
    $STM
    Semiconductors
    Technology

    Goldman reiterated coverage on Roblox with a new price target

    Goldman reiterated coverage of Roblox with a rating of Buy and set a new price target of $125.00 from $140.00 previously

    4/22/26 8:06:58 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Executive Chairman of Board Boersma Travis disposed of 33,022 units of Class B Common Stock (SEC Form 4)

    4 - Dutch Bros Inc. (0001866581) (Issuer)

    4/24/26 5:12:58 PM ET
    $BROS
    Restaurants
    Consumer Discretionary

    Large owner Dm Individual Aggregator, Llc disposed of 13,277 units of Class B Common Stock, decreasing direct ownership by 0.09% to 14,143,857 units (SEC Form 4)

    4 - Dutch Bros Inc. (0001866581) (Issuer)

    4/24/26 5:12:31 PM ET
    $BROS
    Restaurants
    Consumer Discretionary

    Large owner Dm Trust Aggregator, Llc disposed of 19,318 units of Class B Common Stock, decreasing direct ownership by 0.09% to 20,579,218 units (SEC Form 4)

    4 - Dutch Bros Inc. (0001866581) (Issuer)

    4/24/26 5:12:13 PM ET
    $BROS
    Restaurants
    Consumer Discretionary

    $ABVC
    $ACXP
    $AFI
    $AFRM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 14, 2024 - FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

    For Immediate Release: November 14, 2024 The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment of adult and pediatric patients with aromatic L-amino acid decarboxylase (AADC) deficiency. Kebilidi is the first FDA-approved gene therapy for treatment of AADC deficiency. “Clinical advancements in the f

    11/14/24 8:50:18 AM ET
    $CLPT
    $PTCT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mehta Neil bought $136,562,971 worth of Class A Common Shares (7,350,104 units at $18.58) (SEC Form 4)

    4 - Coupang, Inc. (0001834584) (Issuer)

    3/13/26 9:04:18 PM ET
    $CPNG
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Flatley Jay T bought $25,281 worth of shares (1,830 units at $13.81) and sold $11,775 worth of shares (580 units at $20.30), increasing direct ownership by 0.78% to 162,070 units (SEC Form 4)

    4 - Rivian Automotive, Inc. / DE (0001874178) (Issuer)

    3/5/26 5:10:12 PM ET
    $RIVN
    Auto Manufacturing
    Industrials

    Chief Executive Officer Derosa Thomas Joseph bought $3,299 worth of shares (10,000 units at $0.33), increasing direct ownership by 22% to 56,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:58:08 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    $ABVC
    $ACXP
    $AFI
    $AFRM
    SEC Filings

    View All

    Ondas Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

    8-K - Ondas Inc. (0001646188) (Filer)

    4/24/26 4:37:22 PM ET
    $ONDS
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Solana Company filed SEC Form 8-K: Leadership Update

    8-K - Solana Co (0001610853) (Filer)

    4/24/26 4:30:12 PM ET
    $HSDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 424B7 filed by Ondas Inc.

    424B7 - Ondas Inc. (0001646188) (Filer)

    4/24/26 4:22:09 PM ET
    $ONDS
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer

    Webcast scheduled for Monday, April 27, 2026 at 8:00am ET. BOSTON, April 24, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (NASDAQ:CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, announced it will host a webcast on Monday, April 27, 2026 at 8:00am ET to review topline secondary endpoints from its Phase 2/3 COMPANION-002 clinical study assessing tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel in patients with advanced biliary tract cancer (BTC).  Conference Call and Webcast Presentation: Date and Time: Monday, April 27, 2026 at 8:00am ET Toll Fre

    4/24/26 4:00:00 PM ET
    $CMPX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Tradr Launches Leveraged ETFs on AXTI, CPNG, MPWR and STX

    Listings cover stocks involved in trending themes such as data storage and AI compute infrastructure Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched four new leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver two times long (200%) the daily performance of a specific underlying stock. Three of the four ETFs are first-to-market strategies. The following ETFs are expected to open for trading today: Tradr 2X Long AXTI Daily ETF (Cboe: AXTX) – tracks AXT Inc. (NASDAQ:AXTI) Tradr 2X Long CPNG Daily ETF (Cboe: CPNX) – tracks Coupang Inc. (NYSE:CPNG) Tradr 2X Long MPWR Daily ETF (Cboe: MPWX) – tracks Monol

    4/24/26 6:46:00 AM ET
    $AXTI
    $CPNG
    $MPWR
    Semiconductors
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary

    Mawson Infrastructure Group Inc. Becomes Big Digital Energy, Inc.; Receives Nasdaq Listing Determination; Already in Compliance, To Request Hearing

    MIDLAND, Pa., April 23, 2026 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (the "Company") (NASDAQ:MIGI) today announced that it has submitted the relevant documentation with the State of Delaware to update its name to Big Digital Energy, Inc., effective April 24, 2026, and that, subject to approval by Nasdaq, its common stock is expected to begin trading on The Nasdaq Capital Market ("Nasdaq") under the ticker symbol "BGDE" upon market open on April 30, 2026. The Company's CUSIP number will remain unchanged, and no action is required from stockholders in relation to this change. Phil Stanley, Chief Executive Officer of Mawson, commented, "The transition to Big Digital Energy and o

    4/23/26 4:15:00 PM ET
    $MIGI
    Finance: Consumer Services
    Finance

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Financials

    Live finance-specific insights

    View All

    Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer

    Webcast scheduled for Monday, April 27, 2026 at 8:00am ET. BOSTON, April 24, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (NASDAQ:CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, announced it will host a webcast on Monday, April 27, 2026 at 8:00am ET to review topline secondary endpoints from its Phase 2/3 COMPANION-002 clinical study assessing tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel in patients with advanced biliary tract cancer (BTC).  Conference Call and Webcast Presentation: Date and Time: Monday, April 27, 2026 at 8:00am ET Toll Fre

    4/24/26 4:00:00 PM ET
    $CMPX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Groupon Announces Date for First Quarter 2026 Financial Results

    Chicago, Illinois--(Newsfile Corp. - April 23, 2026) - Groupon, Inc. (NASDAQ:GRPN) announced today that it intends to release the company's first quarter 2026 financial results after the market closes on Thursday, May 7, 2026. The company will also host a conference call to answer questions regarding the company's results at 8:00am ET on Friday, May 8, 2026. Investors may submit questions by emailing [email protected] webcast of the conference call can be accessed live at investor.groupon.com. A replay of the webcast will be available through the same link following the conference call, along with other published materials.About Groupon Groupon (www.groupon.com) (NASDAQ:GRPN) is a trusted loc

    4/23/26 7:00:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    STMicroelectronics Reports Q1 2026 Financial Results

    PR No: C3392C    STMicroelectronics Reports Q1 2026 Financial Results   Q126 net revenues at $3.10 billionU.S. GAAP Gross margin at 33.8%. Excluding the Purchase Price Allocation (PPA) effects from the acquisition of NXP's MEMS sensor business, non-U.S. GAAP1 gross margin at 34.1%U.S. GAAP operating income at $70 million (non-U.S. GAAP1 operating income at $171 million) Business outlook at mid-point: Q226 net revenues of $3.45 billion and U.S. GAAP gross margin of 34.8% (non-U.S. GAAP1 gross margin of 35.2%) Geneva, April 23, 2026 – STMicroelectronics N.V. ("ST") (NYSE:STM), a global semiconductor leader serving customers across the spectrum of electronics applications, reported U.S.

    4/23/26 1:00:00 AM ET
    $STM
    Semiconductors
    Technology

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Leadership Updates

    Live Leadership Updates

    View All

    Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer

    SAN MATEO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced the appointment of Andreas Grauer, MD, as Chief Medical Officer, effective April 20, 2026. Sagimet's prior Chief Medical Officer, Eduardo Bruno Martins, MD, DPhil, who will continue to support the Company as an external scientific advisor, has retired effective April 20, 2026. "We are delighted to welcome Dr. Andreas Grauer to our executive leadership team as Chief Medical Officer. Dr. Grauer has an extensive track record in leading clinical development

    4/20/26 7:00:00 AM ET
    $OMER
    $SGMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    As the Counter-Drone Era Goes Mainstream, This Nasdaq AI Defense Stock Just Landed a World Cup Deployment Order

    Issued on behalf of VisionWave Holdings, Inc. Companies mentioned in this commentary include: VisionWave Holdings, Inc. (NASDAQ:VWAV), Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), Red Cat Holdings, Inc. (NASDAQ:RCAT), Ondas Holdings Inc. (NASDAQ:ONDS), Unusual Machines, Inc. (NYSE:UMAC). Key Takeaways: The global counter-drone market has become one of the fastest-growing niches in defense, driven by the proliferation of cheap weaponized UAS across battlefields and public events.VisionWave Holdings (NASDAQ:VWAV) presented its three-pillar technology platform — VisionRF™, Stratum™, and qSpeed™ — to more than 580 investors at the 91st Emerging Growth Conference on April 2,

    4/16/26 9:00:00 AM ET
    $KTOS
    $ONDS
    $RCAT
    Military/Government/Technical
    Industrials
    Radio And Television Broadcasting And Communications Equipment
    Technology

    John Hancock Convenes Global Leaders in Longevity for Third Longer. Healthier. Better. Symposium in Boston

    Massachusetts Governor Maura Healey Joins Speaker Lineup of World-Class Researchers, Scientists, Physicians, Athletes and Innovators New Cardiac Health Support Tools for John Hancock Vitality Members Announced as Heart Disease Remains Top Cause of Death in U.S.  BOSTON, April 13, 2026 /PRNewswire/ - Today, John Hancock kicks off its third Longer. Healthier. Better. Symposium in Boston, convening global leaders across public and private sectors, renowned academics, physicians, health and wellness thought leaders, athletes, and more, for two days to share the latest research and innovations driving the future of longevity.

    4/13/26 9:30:00 AM ET
    $MFC
    Life Insurance
    Finance

    $ABVC
    $ACXP
    $AFI
    $AFRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    SEC Form SC 13G filed by DarioHealth Corp.

    SC 13G - DarioHealth Corp. (0001533998) (Subject)

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary